These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32600852)

  • 1. Acute pancytopenia due to praziquantel treatment for cerebral cysticercosis: A rare case report.
    Zhang Y; Fu Y; Deng H; Li Q; Lai J
    J Infect Chemother; 2020 Oct; 26(10):1082-1085. PubMed ID: 32600852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurocysticercosis. II. Evaluation of treatment with praziquantel].
    Takayanagui OM
    Arq Neuropsiquiatr; 1990 Mar; 48(1):11-5. PubMed ID: 2198859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J; Jung H
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of praziquantel levels in cerebrospinal fluid and plasma in patients with cysticercosis of the central nervous system treated with praziquantel].
    Jia JY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):174-6, 189-90. PubMed ID: 1889331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.
    Sotelo J; del Brutto OH; Penagos P; Escobedo F; Torres B; Rodriguez-Carbajal J; Rubio-Donnadieu F
    J Neurol; 1990 Apr; 237(2):69-72. PubMed ID: 2192018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies.
    Francisca PA; Javier LF; Guadalupe PH; Fernanda GM; Nelly C; Helgi JC; Iliana GH; Susana RI
    Acta Trop; 2020 Feb; 202():105238. PubMed ID: 31669532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary report of praziquantel treatment of cysticercosis patients in Vietnam.
    Pham HT; van Knapen F
    Acta Leiden; 1989; 57(2):229-33. PubMed ID: 2489001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment of cerebral cysticercosis with praziquantel].
    Nii Y; Nakagawa H; Taki T; Nakabayashi T
    No Shinkei Geka; 1988 Aug; 16(9):1083-8. PubMed ID: 3205370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral infarct precipitated by praziquantel in neurocysticercosis--a cautionary note.
    Woo E; Yu YL; Huang CY
    Trop Geogr Med; 1988 Apr; 40(2):143-6. PubMed ID: 3407004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of the therapeutic efficacy of praziquantel against human cysticercosis.
    Rim HJ; Joo KH
    Acta Leiden; 1989; 57(2):235-45. PubMed ID: 2489002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large cerebral infarction during praziquantel therapy in neurocysticercosis.
    Bang OY; Heo JH; Choi SA; Kim DI
    Stroke; 1997 Jan; 28(1):211-3. PubMed ID: 8996514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Praziquantel in the cerebrospinal fluid in neurocysticercosis.
    Spina-França A; Machado LR; Nóbrega JP; Livramento JA; Diekmann HW; Groll E; de Rezende GL
    Arq Neuropsiquiatr; 1985 Sep; 43(3):243-59. PubMed ID: 4091736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical application of diagnostic therapy of praziquantel for suspected cere- bral cysticercosis].
    Li Y; Sun L; Chen C; Yang CM
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2015 Oct; 27(5):517-9. PubMed ID: 26930940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of neurocysticercosis with low-dose praziquantel.
    Pun KK; Wong WT
    Trop Geogr Med; 1984 Sep; 36(3):303-4. PubMed ID: 6506211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis.
    Overbosch D; van de Nes JC; Groll E; Diekmann HW; Polderman AM; Mattie H
    Eur J Clin Pharmacol; 1987; 33(3):287-92. PubMed ID: 3691616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel.
    Palomares-Alonso F; Palencia Hernández G; Rojas-Tomé IS; Jung-Cook H; Pinzón-Estrada E
    Exp Parasitol; 2015 Feb; 149():1-6. PubMed ID: 25500213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation at the HPRT locus in patients with neurocysticercosis treated with praziquantel.
    Montero R; Flisser A; Madrazo I; Cuevas C; Ostrosky-Wegman P
    Mutat Res; 1994 Mar; 305(2):181-8. PubMed ID: 7510029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatment of neurocysticercosis.
    Garg RK
    Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Praziquantel (pyrazinoisoquinolone) in active cerebral cysticercosis.
    van Dellen JR; McKeown CP
    Neurosurgery; 1988 Jan; 22(1 Pt 1):92-6. PubMed ID: 3344093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Trial Of Praziquantal (Embay 8440; Biltricide(R)) On The Dermal And Cerebral Human Cysticercosis.
    Rim HJ; Lee JS; Joo KH; Kim SJ; Won CR; Park CY
    Kisaengchunghak Chapchi; 1982 Dec; 20(2):169-190. PubMed ID: 12902689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.